Contribution of Residual Tumour DNA Testing on the Surgical Bed
NCT05934929 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2026-01-02
Summary
The aim of this study is to evaluate the interest of residual tumour DNA research in the operating bed after squamous cell carcinoma excision.
Conditions
- Squamous Cell Carcinoma of the Oral Cavity
Interventions
- OTHER
-
Circulating tumor DNA detection
biological assessment on operating bed to detect residual circulating tumor DNA
Sponsors & Collaborators
-
Centre Henri Becquerel
lead OTHER
Principal Investigators
-
Lise-Marie Roussel, MD · Centre Henri Becquerel
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-08
- Primary Completion
- 2025-12-22
- Completion
- 2027-12-29
Countries
- France
Study Locations
More Related Trials
-
Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study
NCT02902406 ·Status: UNKNOWN
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN
-
T1 Squamous Cell Carcinomas of the Lip
NCT05610293 ·Status: UNKNOWN
-
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
NCT03614689 ·Status: ACTIVE_NOT_RECRUITING
-
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133 ·Status: RECRUITING
-
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT00900289 ·Status: UNKNOWN
-
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
NCT06606028 ·Status: RECRUITING
-
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT05710679 ·Status: RECRUITING ·Phase: NA
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING ·Phase: NA
-
Spectroscopic Analysis of Tongue Tumor Samples.
NCT05104619 ·Status: UNKNOWN
-
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
NCT05122507 ·Status: UNKNOWN
-
Feasibility of CTCs Isolation for Transcriptomes and Genome Wide Associated Analysis in Post-OP High Risk OSCC Patients.
NCT03917524 ·Status: UNKNOWN
-
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT06905262 ·Status: RECRUITING
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer
NCT05400681 ·Status: UNKNOWN
-
Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance
NCT05138328 ·Status: COMPLETED ·Phase: NA
-
Validation of DNA Methylation Biomarkers for Oral Cancer Detection
NCT02648789 ·Status: COMPLETED
-
ctDNA as a Biomarker for Treatment Response in HNSCC
NCT03540563 ·Status: COMPLETED ·Phase: NA
-
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study
NCT00323726 ·Status: WITHDRAWN
-
Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping
NCT03420846 ·Status: TERMINATED ·Phase: NA
-
STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers
NCT06861621 ·Status: RECRUITING
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
NCT00899704 ·Status: WITHDRAWN
-
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
NCT07327489 ·Status: RECRUITING